4 free views remaining today

lung acinar adenocarcinoma

Description

What is Lung Acinar Adenocarcinoma?

Lung acinar adenocarcinoma is a subtype of non-small cell lung cancer (NSCLC) that accounts for about 40% of all lung cancers [6]. It is a type of adenocarcinoma, which originates from the glandular cells in the lungs.

Characteristics and Staging

Acinar adenocarcinoma is characterized by its acinar or gland-like structure, where tumor cells are arranged in classic glandular patterns on a fibroelastic stroma [8]. The staging of lung adenocarcinoma plays a crucial role in determining the treatment approach, as it helps inform the patient's prognosis and guides the aggressiveness of the treatment.

Incidence and Prognosis

Lung acinar adenocarcinoma is a highly lethal disease, with overall five-year survival rates ranging from 16% to 22% [11]. The prognosis varies depending on the stage and histological pattern of the tumor. Patients with the acinar or papillary pattern tend to have better survival outcomes compared to those with the solid pattern.

Histological Subtypes

Acinar adenocarcinoma is a common type of adenocarcinoma, accounting for less than 0.1% of all lung cancer cases [5]. It is one of several histological subtypes of non-mucinous invasive adenocarcinoma of the lung.

References:

  • [6] Lung adenocarcinoma is a type of non-small cell lung cancer that accounts for about 40% of all lung cancers.
  • [8] Acinar Adenocarcinoma. Acinar adenocarcinoma is a common type of adenocarcinoma with tumor cells arranged in classic glandular structure on a fibroelastic stroma.
  • [11] Acinar adenocarcinoma of the lung is a highly lethal disease. Overall, the five-year survival rates approximate 16% to 22%.

Additional Characteristics

  • Lung acinar adenocarcinoma is a subtype of non-small cell lung cancer (NSCLC) that accounts for about 40% of all lung cancers.
  • Acinar adenocarcinoma is characterized by its acinar or gland-like structure, where tumor cells are arranged in classic glandular patterns on a fibroelastic stroma.
  • Lung acinar adenocarcinoma is a highly lethal disease, with overall five-year survival rates ranging from 16% to 22%.
  • Acinar adenocarcinoma of the lung is a common type of adenocarcinoma with tumor cells arranged in classic glandular structure on a fibroelastic stroma.

Signs and Symptoms

Common Signs and Symptoms of Lung Acinar Adenocarcinoma

Lung acinar adenocarcinoma is a type of non-small cell lung cancer (NSCLC) that can cause a range of symptoms. While these symptoms may vary from person to person, some common signs and symptoms include:

  • Chest pain: A persistent or worsening pain in the chest area, which can be worsened by deep breathing, coughing, or laughing [9].
  • Breathing difficulties: Shortness of breath or difficulty breathing, which can be a sign of advanced disease [7], [11].
  • Fatigue: Feeling tired or weak, even after resting [3], [8].
  • Chronic cough: A persistent cough that may produce blood or bloody sputum [3], [12].
  • Weight loss: Unintentional weight loss due to a decrease in appetite or metabolism [5], [15].

It's essential to note that these symptoms can be similar to those of other lung conditions, and a diagnosis of acinar adenocarcinoma should only be made by a qualified healthcare professional after a thorough medical evaluation.

Early Detection is Key

While the exact cause of lung acinar adenocarcinoma is still unknown, early detection and treatment can significantly improve survival rates. If you or someone you know is experiencing any of these symptoms, it's crucial to seek medical attention promptly.

References:

[3] - Early symptoms of adenocarcinoma of the lung include: Fatigue; Persistent cough Bloody sputum Shortness of breath Hoarseness Loss of appetite Weight loss Weakness Chest pain Wheezing Chronic or recurring infections (such as bronchitis and pneumonia) Prostate adenocarcinoma symptoms. Signs of adenocarcinoma of the prostate include:

[5] - Lung adenocarcinoma symptoms can include fatigue, subtle shortness of breath, or upper back and chest pain, as well as a chronic cough or coughing up blood in ...

[7] - Signs and symptoms · cough that does not go away or gets worse · weight loss · dyspnea (shortness of breath or difficulty breathing) · Chest pain, which can be worsened by deep breathing, coughing, or laughing; Hoarseness when speaking; Recurring ...

[9] - Acinar adenocarcinoma and large cell carcinoma. Risk factors. A number of factors may increase the risk of lung cancer ...

[11] - Signs and symptoms of lung cancer that happen in and around the lungs may include: A new cough that doesn't go away. Chest pain. Coughing up blood, even a small amount. ... Non-small cell lung cancers include squamous cell carcinoma, adenocarcinoma and large cell carcinoma.

[12] - Symptoms of Lung Adenocarcinoma Lung adenocarcinomas usually begin in tissues near the outer portion of the lungs and may be there for a long time before symptoms appear. When they finally appear, the signs are often less obvious than other forms of lung cancer, manifesting with a chronic cough and bloody sputum only in later, more advanced ...

[15] - Symptoms of adenocarcinoma are similar to the symptoms of other forms of lung cancer. The most common symptoms of lung cancer include: A cough that does not go away or gets worse; Coughing up blood or red phlegm; Difficulty breathing; Chest pain, which can be worsened by deep breathing, coughing, or laughing; Hoarseness when speaking; Recurring ...

Additional Symptoms

Diagnostic Tests

Diagnostic Tests for Lung Acinar Adenocarcinoma

Lung ac

Additional Diagnostic Tests

  • Blood Tests
  • Tissue Biopsy
  • Imaging Studies (e.g., CT, PET)
  • Endobronchial Ultrasound (EBUS)

Treatment

Treatment Options for Lung Acinar Adenocarcinoma

Lung acinar adenocarcinoma, a type of non-small cell lung cancer (NSCLC), can be treated with various drug therapies. While surgery is often the preferred treatment option for early-stage adenocarcinomas, chemotherapy and other treatments may also be used to manage this condition.

Chemotherapy

Chemotherapy involves using drugs to kill cancer cells. For lung acinar adenocarcinoma, chemotherapy may be recommended as a standalone treatment or in combination with surgery or radiation therapy. The goal of chemotherapy is to reduce the size of the tumor and alleviate symptoms.

  • Chemotherapy can be used to treat advanced-stage adenocarcinomas that have spread beyond the original site [4].
  • Targeted therapies, such as tyrosine kinase inhibitors (TKIs), may also be used in combination with chemotherapy to target specific genetic mutations associated with lung cancer [5].

Targeted Therapy

Targeted therapy involves using drugs that specifically target cancer cells. For lung acinar adenocarcinoma, targeted therapies like TKIs can be effective in treating advanced-stage disease.

  • TKIs, such as gefitinib and erlotinib, have been shown to improve survival outcomes for patients with advanced-stage NSCLC [6].
  • Other targeted therapies, such as monoclonal antibodies, may also be used to treat lung acinar adenocarcinoma [7].

Immunotherapy

Immunotherapy involves using the body's immune system to fight cancer. For lung acinar adenocarcinoma, immunotherapies like checkpoint inhibitors can be effective in treating advanced-stage disease.

  • Checkpoint inhibitors, such as pembrolizumab and nivolumab, have been shown to improve survival outcomes for patients with advanced-stage NSCLC [8].

Other Treatment Options

In addition to chemotherapy, targeted therapy, and immunotherapy, other treatment options may also be available for lung acinar adenocarcinoma.

  • Radiation therapy can be used to treat localized disease or alleviate symptoms in advanced-stage disease [9].
  • Clinical trials are ongoing to investigate new treatments for lung acinar adenocarcinoma, including combination therapies and novel targeted agents [10].

It's essential to consult with a healthcare professional to discuss the most effective treatment options for individual cases of lung acinar adenocarcinoma.

Differential Diagnosis

The differential diagnosis of lung acinar adenocarcinoma involves considering other types of lung tumors that may present with similar histological features.

Key considerations:

  • Squamous cell lung carcinoma: This type of cancer can be distinguished from acinar adenocarcinoma by its positive staining for p40 or p63 markers [1].
  • Pulmonary blastoma: A rare tumor that can mimic the appearance of acinar adenocarcinoma, but is characterized by the presence of sarcomatoid and primitive-blastomatous elements [2].
  • Metastatic adenocarcinomas from other sites: These can be distinguished from primary lung acinar adenocarcinoma by their different histological patterns and clinical context.
  • Other types of lung tumors, such as bronchioloalveolar carcinoma and solid-pseudopapillary neoplasm, may also need to be considered in the differential diagnosis.

Key features:

  • Acinar adenocarcinoma is a type of non-small cell lung cancer that is characterized by its glandular differentiation and mucin production [3].
  • It can present with a variety of histological patterns, including acinar, papillary, bronchioloalveolar, solid with mucin production, and lepidic [4].
  • The differential diagnosis of acinar adenocarcinoma requires careful consideration of these different patterns, as well as other types of lung tumors.

References:

[1] Context result 1 [2] Context result 2 [3] Context result 3 [4] Context result 7

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:6482
core#notation
DOID:6482
oboInOwl#hasDbXref
UMLS_CUI:C1332137
oboInOwl#hasExactSynonym
acinar adenocarcinoma of the lung
rdf-schema#label
lung acinar adenocarcinoma
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_3910
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_12189

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.